<DOC>
	<DOCNO>NCT01187862</DOCNO>
	<brief_summary>The purpose study ass whether cocktail seven approve drug ( so-called `` Basel cocktail '' ) use simultaneous phenotyping CYP1A2 , CYP2B6 , CYP2C9 , CYP2C19 , CYP2D6 , CYP2E1 CYP3A4 .</brief_summary>
	<brief_title>Pharmacokinetic Study Investigate Low-dose Combinations Cocktail Seven Drugs Simultaneous Phenotyping Cytochromes</brief_title>
	<detailed_description />
	<mesh_term>Metoprolol</mesh_term>
	<mesh_term>Losartan</mesh_term>
	<mesh_term>Caffeine</mesh_term>
	<mesh_term>Midazolam</mesh_term>
	<mesh_term>Omeprazole</mesh_term>
	<mesh_term>Efavirenz</mesh_term>
	<mesh_term>Chlorzoxazone</mesh_term>
	<criteria>Signed informed consent Male age 18 45 year No clinically significant finding physical examination Body mass index ( BMI ) 18 28 kg/m2 Systolic blood pressure ( SBP ) 100145 mmHg , diastolic blood pressure ( DBP ) 5090 mmHg , heart rate ( HR ) 4590 bpm ( inclusive ) 12lead electrocardiogram ( ECG ) without clinically relevant abnormality Hematology clinical chemistry result deviate normal range clinically relevant extent Negative result urine drug screen Ability communicate well investigator understand comply requirement study Known hypersensitivity excipients drug formulation Treatment another investigational drug within 30 day prior screen History clinical evidence alcoholism drug abuse within 3year period prior screen Excessive caffeine consumption , define mor 800 mg per day History clinical evidence disease and/or existence surgical medical condition , might interfere absorption , distribution , metabolism excretion study drug Smoking within last 3 month prior screen Previous treatment prescribe OTC medication ( include herbal medicine St John 's Wort ) within 2 week prior screen Loss 250 ml blood within 3 month prior screen Any circumstance condition , , opinion investigator , may affect full participation study compliance protocol Legal incapacity limit legal capacity screening</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>April 2015</verification_date>
</DOC>